Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome (Surfactant 1)

This study has been completed.
Information provided by:
NICHD Neonatal Research Network Identifier:
First received: September 15, 2010
Last updated: June 3, 2015
Last verified: June 2015